Compagnie Lombard Odier SCmA’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-112	Closed	-$10K	–	599
2021 Q4	$10K	Hold	112	–	–	﹤0.01%	613
2021 Q3	$9K	Hold	112	–	–	﹤0.01%	594
2021 Q2	$9K	Hold	112	–	–	﹤0.01%	588
2021 Q1	$8K	Hold	112	–	–	﹤0.01%	606
2020 Q4	$10K	Hold	112	–	–	﹤0.01%	523
2020 Q3	$9K	Hold	112	–	–	﹤0.01%	462
2020 Q2	$14K	Hold	112	–	–	﹤0.01%	456
2020 Q1	$9K	Hold	112	–	–	﹤0.01%	434
2019 Q4	$9K	Hold	112	–	–	﹤0.01%	445
2019 Q3	$8K	Hold	112	–	–	﹤0.01%	459
2019 Q2	$10K	Sell	112 -2,500	-96%	-$223K	﹤0.01%	445
2019 Q1	$232K	Buy	2,612 +2,500	+2,232%	+$222K	0.01%	276
2018 Q4	$10K	Hold	112	–	–	﹤0.01%	474
2018 Q3	$11K	Hold	112	–	–	﹤0.01%	495
2018 Q2	$11K	Hold	112	–	–	﹤0.01%	530
2018 Q1	$9K	Sell	112 -112	-50%	-$9K	﹤0.01%	537
2017 Q4	$20K	Sell	224 -688	-75%	-$61.4K	﹤0.01%	565
2017 Q3	$84K	Sell	912 -3,050	-77%	-$281K	﹤0.01%	454
2017 Q2	$360K	Sell	3,962 -2,000	-34%	-$182K	0.01%	300
2017 Q1	$524K	Sell	5,962 -4,000	-40%	-$352K	0.02%	280
2016 Q4	$825K	Sell	9,962 -11,500	-54%	-$952K	0.02%	275
2016 Q3	$1.99M	Sell	21,462 -17,700	-45%	-$1.64M	0.06%	186
2016 Q2	$3.05M	Buy	39,162 +25,106	+179%	+$1.95M	0.09%	157
2016 Q1	$1.16M	Buy	14,056 +9,944	+242%	+$819K	0.04%	239
2015 Q4	$431K	Buy	4,112 +4,000	+3,571%	+$419K	0.01%	342
2015 Q3	$12K	Hold	112	–	–	﹤0.01%	736
2015 Q2	$15K	Hold	112	–	–	﹤0.01%	736
2015 Q1	$14K	Hold	112	–	–	﹤0.01%	882
2014 Q4	$10K	Sell	112 -5,150	-98%	-$460K	﹤0.01%	713
2014 Q3	$380K	Buy	5,262 +5,150	+4,598%	+$372K	0.02%	381
2014 Q2	$7K	Hold	112	–	–	﹤0.01%	850
2014 Q1	$8K	Hold	112	–	–	﹤0.01%	830
2013 Q4	$8K	Buy	+112	New	+$8K	﹤0.01%	815